DE60212143D1 - Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera - Google Patents

Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera

Info

Publication number
DE60212143D1
DE60212143D1 DE60212143T DE60212143T DE60212143D1 DE 60212143 D1 DE60212143 D1 DE 60212143D1 DE 60212143 T DE60212143 T DE 60212143T DE 60212143 T DE60212143 T DE 60212143T DE 60212143 D1 DE60212143 D1 DE 60212143D1
Authority
DE
Germany
Prior art keywords
chronic
hautulcera
thrombin
treatment
peptide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60212143T
Other languages
English (en)
Other versions
DE60212143T2 (de
Inventor
H Carney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capstone Therapeutics Corp
Original Assignee
Orthologic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthologic Corp filed Critical Orthologic Corp
Application granted granted Critical
Publication of DE60212143D1 publication Critical patent/DE60212143D1/de
Publication of DE60212143T2 publication Critical patent/DE60212143T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60212143T 2001-07-27 2002-01-16 Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera Expired - Lifetime DE60212143T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30819801P 2001-07-27 2001-07-27
US308198P 2001-07-27
PCT/US2002/001151 WO2003013569A2 (en) 2001-07-27 2002-01-16 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Publications (2)

Publication Number Publication Date
DE60212143D1 true DE60212143D1 (de) 2006-07-20
DE60212143T2 DE60212143T2 (de) 2007-04-12

Family

ID=23192964

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212143T Expired - Lifetime DE60212143T2 (de) 2001-07-27 2002-01-16 Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera

Country Status (12)

Country Link
US (3) US7049294B2 (de)
EP (1) EP1414487B1 (de)
JP (1) JP4192093B2 (de)
CN (1) CN100509055C (de)
AT (1) ATE328606T1 (de)
AU (1) AU2002236768B2 (de)
CA (1) CA2455756C (de)
DE (1) DE60212143T2 (de)
DK (1) DK1414487T3 (de)
ES (1) ES2271216T3 (de)
HK (1) HK1065719A1 (de)
WO (1) WO2003013569A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2271216T3 (es) * 2001-07-27 2007-04-16 Orthologic Corp. Uso de los peptidos derivados de la trombina para la terapia de las ulceras dermicas cronicas.
AU2003247848B2 (en) * 2002-07-02 2006-12-21 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
CA2491052A1 (en) * 2002-07-02 2004-02-19 The Board Of Regents, The University Of Texas System Thrombin peptide derivatives
CN1913917B (zh) 2003-12-31 2012-02-01 正统逻辑公司 凝血酶肽衍生物的药物组合物
WO2007035406A1 (en) * 2005-09-16 2007-03-29 Orthologic Corp. Antibodies to complementary peptides of thrombin or portions thereof
WO2008124172A1 (en) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Combination therapy for chronic dermal ulcers
US20110117075A1 (en) * 2008-03-26 2011-05-19 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
CA2722620A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
EP2280722A2 (de) * 2008-03-26 2011-02-09 Orthologic Corp. Verfahren zur behandlung von degenerativen erkrankungen
WO2009142679A2 (en) * 2008-03-26 2009-11-26 Orthologic Corp. Methods for treating acute myocardial infarction
GB0916576D0 (en) 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
EP2538874A4 (de) * 2010-02-24 2017-06-21 Syneron Medical Ltd. Körperformgebungsvorrichtung
US8806615B2 (en) 2010-11-04 2014-08-12 Mcafee, Inc. System and method for protecting specified data combinations
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
AU5638096A (en) 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
ES2271216T3 (es) * 2001-07-27 2007-04-16 Orthologic Corp. Uso de los peptidos derivados de la trombina para la terapia de las ulceras dermicas cronicas.

Also Published As

Publication number Publication date
DE60212143T2 (de) 2007-04-12
JP4192093B2 (ja) 2008-12-03
CA2455756C (en) 2013-04-02
DK1414487T3 (da) 2006-10-09
US20060241049A1 (en) 2006-10-26
US20090029923A1 (en) 2009-01-29
US7833982B2 (en) 2010-11-16
ATE328606T1 (de) 2006-06-15
JP2004538320A (ja) 2004-12-24
US7049294B2 (en) 2006-05-23
ES2271216T3 (es) 2007-04-16
EP1414487B1 (de) 2006-06-07
WO2003013569A3 (en) 2003-12-11
CN1556711A (zh) 2004-12-22
CA2455756A1 (en) 2003-02-20
US20040209819A1 (en) 2004-10-21
US7378500B2 (en) 2008-05-27
WO2003013569A2 (en) 2003-02-20
HK1065719A1 (en) 2005-03-24
CN100509055C (zh) 2009-07-08
EP1414487A2 (de) 2004-05-06
AU2002236768B2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
DE60212143D1 (de) Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DE502005005659D1 (de) Verkürzte wundheilungsprozesse mittels neuartiger faservliese
ATE442148T1 (de) Kombinationstherapie durch glukoseresorptionshemmer und retinoid x rezeptorenmodulatoren
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
DE602004013792D1 (de) Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
DE60035232D1 (de) (S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
DE60231295D1 (de) R und ppar modulatoren
ATE257013T1 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
ATE348631T1 (de) Verwendung von plasminogen zur heilung von zerbrochenen trommelfellen
DK1397681T3 (da) Fremgangsmåde til identificering af midler til behandling af diabetes
ATE402699T1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
DE60221884D1 (de) Mediziniscer verband
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE50308460D1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
WO2004053107A3 (en) Methods for treating diabetes
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition